— David Balto, an antitrust attorney who has been critical of the PBM industry model, tells Drug Benefit News, speaking about the pricing dispute between Anthem Inc. and Express Scripts Holding Co.
Tuesday, May 16, 2017
"If the largest buyer in the market is sort of saying, 'We've been hoodwinked,' that is going to ...
... to set off alarm
bells for all the other buyers. There's increasing evidence that the effect of
PBMs and the rebate scheme is to increase the price of drugs, and this
spotlights that."
— David Balto, an antitrust attorney who has been critical of the PBM industry model, tells Drug Benefit News, speaking about the pricing dispute between Anthem Inc. and Express Scripts Holding Co.
— David Balto, an antitrust attorney who has been critical of the PBM industry model, tells Drug Benefit News, speaking about the pricing dispute between Anthem Inc. and Express Scripts Holding Co.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment